SCHEMBL19852065

SCHEMBL19852065

CC/C(=C\C=C(C)C)C(N)=O

nearest known ligand 0.35

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.32
ALOX15 P16050 1/20 0.32
BLM P54132 1/20 0.32
PMP22 Q01453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19852064 0.82 ALDH1A1 (0.32) TDP1ALDH1A1
SCHEMBL16674848 0.78 TDP1 (0.36) TDP1ALDH1A1
SCHEMBL11124467 0.78
SCHEMBL28427748 0.76
SCHEMBL22586427 0.76
SCHEMBL13716242 0.76 CES1 (0.38) ALDH1A1
SCHEMBL4742487 0.74
SCHEMBL11372614 0.74
SCHEMBL2542743 0.73 TDP1 (0.36) TDP1ALDH1A1LMNAALOX15BLM
SCHEMBL24794903 0.73 TRPA1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed